The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain

医学 可视模拟标度 疼痛评分 物理疗法 急诊科 疼痛评估 评定量表 前瞻性队列研究 麻醉 显著性差异 疼痛量表 外科 疼痛管理 内科学 精神科 发展心理学 心理学
作者
A-M Kelly
出处
期刊:Emergency Medicine Journal [BMJ]
卷期号:18 (3): 205-207 被引量:950
标识
DOI:10.1136/emj.18.3.205
摘要

OBJECTIVE: To determine whether minimum clinically significant difference in visual analogue scale (VAS) pain score varies according to the severity of pain reported. METHOD: Prospective descriptive study of adult patients in an urban emergency department (ED). On presentation to the ED, patients marked the level of their pain on a 100 mm, non-hatched VAS scale. At 20 minute intervals thereafter they were asked to give a verbal categorical rating of their pain as "a lot better", "a little better", "much the same", "a little worse" or "much worse" and to mark the level of pain on a VAS scale of the same type as used previously. It was pre-defined that patients with VAS pain scores of 30 mm or less would be categorised as having mild pain, those with scores of 70 mm or more were categorised as having severe pain and those from 31 mm to 69 mm, moderate pain. The minimal clinically significant difference (MCSD) in VAS pain score was defined as the mean difference between current and preceding scores when the subject reported "a little worse" or "a little better" pain. RESULTS: 156 patients were enrolled in the study, yielding 88 evaluable comparisons where pain was rated as "a little better" or "a little worse". The MCSD in VAS score in the group overall was 12 mm (95%CI 9 mm to 15 mm). MCSD in VAS score for the "mild pain" group was 11 mm (95%CI 4 mm to 18 mm), for the "moderate pain" group 14 mm (95%CI 10 mm to 18 mm) and for the severe pain group, 10 mm (95%CI 6 mm to 14 mm). There is no statistical difference between the MCSD in VAS score between the severity groups. CONCLUSIONS: The MCSD in VAS pain score does not differ with the severity of pain being experienced.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
脑洞疼应助Derrick采纳,获得10
1秒前
2秒前
微笑浩轩发布了新的文献求助10
2秒前
葛二蛋完成签到 ,获得积分20
2秒前
SECRET发布了新的文献求助10
3秒前
4秒前
wanci应助MM采纳,获得10
4秒前
Arthur发布了新的文献求助10
4秒前
4秒前
九歌发布了新的文献求助10
5秒前
赘婿应助门先生采纳,获得10
5秒前
万能图书馆应助GJ采纳,获得10
5秒前
辛夷发布了新的文献求助10
5秒前
QQ完成签到,获得积分10
6秒前
桐桐应助Su采纳,获得10
6秒前
7秒前
潇洒寄云发布了新的文献求助10
7秒前
mn完成签到,获得积分10
7秒前
领导范儿应助CKW采纳,获得10
7秒前
净坛使者完成签到,获得积分10
8秒前
8秒前
小志发布了新的文献求助200
9秒前
曾文治完成签到,获得积分10
9秒前
zhaolihua完成签到,获得积分20
10秒前
10秒前
外向的汝燕完成签到,获得积分10
10秒前
Nacsion发布了新的文献求助10
10秒前
李爱国应助Thorns采纳,获得10
11秒前
无聊的汲完成签到 ,获得积分10
12秒前
27完成签到,获得积分10
12秒前
Sue完成签到,获得积分10
13秒前
13秒前
LL发布了新的文献求助20
14秒前
14秒前
14秒前
dz678完成签到,获得积分10
15秒前
宋浩奇完成签到 ,获得积分10
15秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7300720
求助须知:如何正确求助?哪些是违规求助? 8919104
关于积分的说明 18889966
捐赠科研通 6965562
什么是DOI,文献DOI怎么找? 3211226
关于科研通互助平台的介绍 2380360
邀请新用户注册赠送积分活动 2187955